Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

Volume: 37, Issue: 30, Pages: 2738 - 2745
Published: Jun 4, 2019
Abstract
PURPOSEImmune checkpoint inhibitor (ICI) therapy often is suspended because of immune-mediated diarrhea and colitis (IMDC). We examined the rate of and risk factors for IMDC recurrence after ICI...
Paper Details
Title
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
Published Date
Jun 4, 2019
Volume
37
Issue
30
Pages
2738 - 2745
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.